Skip to main content

Home/ health information/ Group items tagged act

Rss Feed Group items tagged

pharmacybiz

Security of tenure:Commercial tenants rules set to change - 0 views

  •  
    Nearly 70 years ago the UK Government recognised the imbalance of power between commercial landlords and tenants and passed the Landlord and Tenant Act 1954 (the Act), giving most commercial tenants a right of security of tenure. What is security of tenure? The Act grants tenants of business premises (so this would include pharmacy tenants) the right when the fixed term of their lease has ended to remain in occupation of the premises and the right to apply for the grant of a new lease. The landlord can only object to the grant of the new lease of the premises to the tenant, and therefore regain possession of the property on certain grounds set out in the Act. The parties to a lease can contract outside the provisions of the Act and where this is the case, a tenant would not have security of tenure. Most landlords will insist on no security of tenure where a lease is granted for a short term. As pharmacy leases have tended to be granted for longer terms (usually between 10 and 15 years) pharmacy tenants often have security of tenure. The Act sets out strict procedures which need to be followed to both contract outside the provisions of security of tenure and also to exercise the security of tenure rights granted by the Act. Pharmacists should take legal advice before agreeing to a pharmacy lease being excluded from the Act, and also at the end of their lease term whether or not they have security of tenure. If the lease is contracted outside of the Act, advice should be sought on agreeing new lease terms, if the pharmacist wishes to remain, as there will be no right to do so beyond the end of the lease term. If the lease is protected by the security of tenure provisions of the Act, advice should still be sought, as the Act prescribes a formal notice procedure that both the landlord and tenant must adhere to, before a new lease can be granted.
anonymous

Wheelchair : Handicap Products: International Disability Day Schemes and Programmes - 0 views

  •  
    International day for persons with disabilities on 3rd December - Note on schemes for the welfare of persons with disabilities and concessions available to them. The Government of India is committed for the realization of full participation, protection of rights, and equal opportunities to all including persons with disabilities. India is a country where most of the population lives in the rural areas and accessing the health and rehabilitation services has always been a challenge. In a Backgrounder issued yesterday, a brief summary of the major steps initiated by the Ministry of Social Justice & Empowerment in this direction were given. Following is the Background Note on the legislative and Institutional framework along with the major schemes of the Ministry of Social Justice & Empowerment for the welfare of the People with Disabilities (PwDs). The Note also contains information on facilities and concessions available to PwDs under other central schemes which are being run by other Union Ministries. OFFER ON INTERNATIONAL DISABILITY DAY Wheelchair @ 4499 INR Tricycle @ 6500 INR Legislative Framework: There are four important legislations dealing on disabilities issues- The Persons with Disabilities (Equal Opportunities, Protection of Rights and Full Participation) Act, 1995, has laid the foundation of recognition of rights for Persons with Disabilities and has facilitated development of specific programmes for their education, rehabilitation, employment, non-discrimination and social security. The Rehabilitation Council of India Act, 1992 regulates and monitors training of rehabilitation professionals and personnel. The National Trust for the welfare of Persons with Autism, Cerebral Palsy, Mental Retardation and Multiple Disabilities Act, 1999, aims at enabling and empowering persons with disabilities to live independently as fully as possible in their community. Mental Health Act, 1987, address to the specific needs of persons with ment
pharmacybiz

Nexium Control's Insights on Heartburn Trends - 0 views

  •  
    Nexium Control, the UK's number one selling heartburn product for 24-hour protection1, has commissioned research to explore consumer attitudes to heartburn awareness of the different products on the market in Great Britain and Ireland (1,500 UK and 500 IE respondents). The research found that 53% of respondents usually opt for short-acting treatments to heartburn2, despite longer-acting products being able to provide relief over a 24-hour period. The research from Nexium Control revealed that 54% of people surveyed wished there was a product that managed symptoms for longer3, with 55% of respondents agreeing that short-acting treatments only last a maximum of five hours4. To help their patients understand there are longer-acting options available, pharmacists can provide information and guidance on treatments, such as proton pump inhibitors like Nexium Control. Shorter-acting products, which shoppers often reach for, work by either neutralising the acid already in the stomach or by forming a layer that floats to the top of the stomach, stopping acid rising into the food pipe. Double action treatments which utilise both methods are also available. Containing esomeprazole, Nexium Control reduces the production of stomach acid for up to 24-hour protection with just one pill, treating the cause and symptoms of heartburn - allowing time for the oesophagus to recover from the acid irritation.
anonymous

Wheelchair : Handicap Products: Facilities For Disabilities In India Under Disability A... - 0 views

  •  
    Facilities For Disabilities In India Under Disability Act of 1995 India's Disability Act of 1995 provides various facilities for both children and adults with disabilities in India. Under the Disabilities Act of India, children with disabilities have the right to free education until they reach the age of eighteen in schools that are integrated, or in 'special,' schools. Children with disabilities have the right to appropriate transportation, removal of architectural barriers, as well as the restructuring of curriculum and modifications in the examination system. Scholarships, uniforms, books, and teaching materials are all provided to children with disabilities for free in India. Children with disabilities in India have access to special schools that are equipped with vocational training facilities, and non-formal education. India provides training institutions for teachers in order to establish manpower. Parents of children with disabilities in the nation can move to an appropriate court for the redress of grievances in regards to their children with disabilities; Mobility Products for Handicapped. Parents of children with disabilities in India are required to obtain a, 'disability certificate,' in order to access the facilities mentioned above; they can obtain this certificate from their nearest government hospital, where an Identity Card from the, 'Office of the Commissioner for Disabilities,' will issue it. People in rural areas can obtain this Identity Card from their Block Development Officer's Office (BDO). Side Wheel Attachment for Activa Recent Disability Figures in India: At least 1.2 million people with disabilities in India are living in households consisting only of people with disability. While the total people with disabilities increased by just over 22 per cent over a decade, from almost 22 million in the Census 2001 to 26.8 million in 2011, the number of people with disabilities living on their own has nearly doubled, jumpin
pharmacybiz

LAW: Balancing act of medicine supply - 0 views

  •  
    The Equality Act (which replaced the Disability Discrimination Act in 2010) is often cited as a reason for supplying medicines in a compliance aid. This is a complex piece of legislation, but, in essence, provides a statutory duty on businesses to make "reasonable adjustments" in relation to the service that they provide to take into account any relevant disability of a service-users. This statutory obligation might include the provision of a compliance aid where a patient would be at a "substantial disadvantage" without. However, the need to provide medicines in a compliance aid under the Equality Act needs careful consideration and is a balancing exercise. The NHS Terms of Service for community pharmacies in England state that medicines should be provided in original packs save in certain circumstances, which include because of patient needs.
pharmacybiz

Hub and Spoke Dispensing Models Set to Transform UK Pharmacy - 0 views

  •  
    The Department of Health and Social Care (DHSC) has finally published its response to the 2022 consultation on hub and spoke dispensing. Considering the consultation evidence and further discussions, the government has expressed its intention to progress the proposals for enabling hub and spoke models across different legal entities as soon as possible. This will be achieved by using the enabling powers outlined in Part 2 of the Medicines and Medical Devices Act 2021 (MMDA) to amend the Medicines Act 1968 and the HMRs. Furthermore, the DHSC has decided to proceed with the implementation of the two models of hub and spoke dispensing that it consulted on. The government response to the consultation reads: "Having considered the responses, the government intend to proceed to implement the necessary changes to medicines legislation to remove the current restrictions that prevent the hub and spoke dispensing models from operating across different legal entities found in section 10 of the Medicines Act 1968.
pharmacybiz

File Your Company Accounts on Time:Personal liability - 0 views

  •  
    All companies must send their accounts to Companies House each year. Recent evidence suggests that UK companies are increasingly struggling to file their accounts on time, with around 213,000 private companies reportedly missing their deadline in 2019-2020, resulting in over £93 million of penalties being issued. Over a fifth of companies that filed their accounts late that year had also filed late in the previous year. Under the Companies Act 2006 ("the Act"), the deadline for private companies to file their annual accounts is nine months from the end of the accounting reference period. There are slightly different rules for filing your first set of annual accounts and if these cover a period of more than 12 months, you must deliver them to Companies House within 21 months of the date of incorporation or 3 months from the accounting reference date, whichever is longer. Not filing your accounts at Companies House in a timely manner is also a criminal offence (under section 451 of the Act) and directors can be personally fined in the criminal courts. It is likely to come as a shock to most company directors who receive a summons to attend the Magistrates' Court in Cardiff for a criminal prosecution, particularly directors in larger pharmacy companies where directors are often detached from the preparation of accounts and senior financial staff and accountants are instructed to take care of such matters.
iyus qobain

Nymphomax Female Libido Enhancer - 1 Bottle - 60 Pills - Maximum Strength, Fast Acting ... - 0 views

  •  
    Nymphomax Female Libido Enhancer - 1 Bottle - 60 Pills - Maximum Strength, Fast Acting Female Libido Enhancement Supplement for Women - with price: $59.95 - Nymphomax is the extreme key for boosting a lady's charisma. Nymphomax holds just the most powerful aphrodisiacs and climax upgrade herbs.
pharmacybiz

Phoenix MD:Govt to reverse decline of community pharmacy UK - 0 views

  •  
    A winter NHS crisis is inevitable unless the government acts now to reverse the worrying decline in community pharmacies. Years of government underfunding could see 3,000 pharmacies in England - around a third of the network - having no option but to shut their doors to patients in the next few years. That figure is based on independent assessments from Ernst & Young and UCL/LSE healthcare professors: it is not scaremongering - it is the reality the country faces. Fifty per cent of pharmacies are already in financial distress because government funding has been falling in real terms since 2019 and that figure is predicted to rise to 75 per cent within the next two years. The government needs to act now and invest in pharmacy or sleepwalk into a healthcare disaster as we have seen with access to dentistry care. Prescription volumes have risen consistently year-on-year by roughly 2 per cent which means fewer pharmacies doing more work and under greater pressure than a decade ago. Ten years ago around 11,200 pharmacies in England were dispensing roughly 79,000 prescriptions; nowadays around 11,500 are dispensing roughly 89,000 prescriptions. The secretary of state recently asked pharmacy to do more to avoid a winter NHS crisis and at the same time said there will be no new money to pay for those additional services. This at a time when the network is in decline with random unplanned pharmacy closures - 640 closures since 2016 - and pharmacy staff face huge workload pressures as prescription demand is increasing year-on-year. The government's approach to pharmacy literally does not add up: the pharmacy contract is not fit-for-purpose now let alone dealing with a NHS winter crisis.
pharmacybiz

NICE recommends first long-acting injectable treatment for HIV-1 infection - 0 views

  •  
    In its first, the National Institute for Health and Care Excellence has recommended the use of long-acting injectable treatment for HIV-1 infection in adults, making around 13,000 people eligible for treatment with cabotegravir with rilpivirine in England. The new treatment aims to keep the number of virus particles in the blood so low that it cannot be detected or transmitted between people. Current treatment for HIV‑1 is lifelong antiretroviral tablets taken each day. Use of cabotegravir with rilpivirine is recommended when there is no evidence tosuspect viral resistance, and no previous failure of other anti-HIV-1 medicines. "Clinical trial results show that cabotegravir with rilpivirine is as effective as oralantiretrovirals at keeping the viral load low," NICE stated. Both are administered as two separate injections every two months, after an initial oral (tablet) lead-in period.
robert1488stp

Substance Use Disorder Long-Acting Injectables: Naltrexone and Buprenorphine | eMedEvents - 0 views

  •  
    The Substance Use Disorder Long-Acting Injectables: Naltrexone and Buprenorphine is organized by the American Association of Psychiatric Pharmacists. Outline a plan for monitoring and follow up of a patient receiving naltrexone LAI or buprenorphine LAI.
johnpiter

Measuring "Success" - 0 views

  •  
    Measuring ministry impact with numbers is biblical. The book of Acts uses numbers to describe the impact of the gospel - about 3,000 baptized (Acts 2:41),
Roland Savage

Affordable Care Act Coverage USA - Hip Hop Health Care - 0 views

  •  
    The Affordable Care Act expands medical coverage for thousands of Americans. Enroll now for 2016 coverage starting November 1, 2015. Call now at 1-844-414-4442 for getting the best advice form our expert.
Satinder Singh

IBS and AYURVEDA - 0 views

  •  
    In ayurveda, we have some basic rules for quality life one of such rule is "If your GIT ( Gastero intestinal Tract ) is good you can enjoy good life". It was told by our grandparents to eat only when you feel hungry and eat according to your stomach. Always, eat less then what you want because totally filling your stomach with food can cause improper digestion of food when these improper digested food particles circulate in our body they cause disease. But we in modern lifestyle act totally against these rules. We eat whenever we want without any hunger. When are at home, we eat breakfast, lunch , dinner then we go for shopping we eat burger or chat papri etc., we go to someone's house we eat biscuits and drink tea or cold drinks. We never give rest to our stomach. Food is first pillar of Quality life. It act as fuel of our body. But what will happen if we have food but improper functioning system(GIT) to digest or use this fuel. GIT is a type of pipe where food is chewed in small particles in mouth then digested in stomach, energy from food is absorbed from intestine, waste particle is stored in rectum to excrete after proper interval. Food takes its specified time in each part of GIT. But what will happen if this specified time become shorter. Then you will feel colic pain stomach which relieve after defecation. You feel urge to defecate 30 mins to 1 hour after meal. You start thinking thrice before eating any food. This type of disease is called Irritable Bowel Syndrome (IBS). Dr. Satinder is Ayurvedic doctor in ambala having years of experience in this field. He has helped many patients during these years. He will not only help you in coming out of such problems but will help you mentally to live a healthy life.
  •  
    In ayurveda, we have some basic rules for quality life one of such rule is "If your GIT ( Gastero intestinal Tract ) is good you can enjoy good life". It was told by our grandparents to eat only when you feel hungry and eat according to your stomach. Always, eat less then what you want because totally filling your stomach with food can cause improper digestion of food when these improper digested food particles circulate in our body they cause disease.
robertwilliam02

Research Nester Reviews that the Global Anti-Obesity Drugs Market is to be Valued High ... - 0 views

  •  
    The global anti-obesity Drugs Market is segmented in by product:-Peripherally acting anti-obesity agents, centrally acting anti-obesity drugs; by mode of action:-Fat Absorption Inhibition, Food Intake Suppression:- Noradrenergic Drugs, Serotoninergic Drugs, Adrenergic Drug, Others; Increase Thermogenesis; Segmentation by Type:- Prescription Drugs, Over the Counter Drugs; Segmentation by Distribution Channel:- Hospital Pharmacy, Retail Pharmacy and by regions. Anti-Obesity Drugs Market is anticipated to mask a significant CAGR during the forecast period i.e. 2015-2021. Anti-obesity drugs are pharmacological agents that are used to lose cholesterol and reduce the body weight. These drugs generally show their action by altering the fundamental functioning of the normal body by utilization of calories or by altering the appetite. The World Health Organization reveals that global obesity has more than doubled since 1980, with over 1.9 billion adults overweight in 2014, of which, more than 600 million were obese
pharmacybiz

Pharmacist Supervision : The Divided World Of It - 0 views

  •  
    Pharmacist supervision has been the subject of debate for as long as I can remember. Strikingly, no one is sure what supervision requires. The Human Medicines Regulations 2012 say it is a criminal offence to sell or supply Pharmacy medicines or Prescription Only Medicines unless a pharmacist makes the sale or supply or, if the transaction is carried out by a non-pharmacist, that person acts under the supervision of a pharmacist. Over the years, some people have argued that supervision requires a clinical check. Others say it requires an accuracy assessment. Yet others have asserted that it requires a final check before a medicine leaves the pharmacy. Things are made more uncertain by the NHS terms of service which require prescription medicines to be supplied under the direct supervision of a pharmacist. No one knows what the word "direct" adds. The wording of the Human Medicines Regulations is not identical to the wording of earlier legislation. In particular, on the only occasions when the courts have been called upon to interpret the requirement for supervision, the Pharmacy and Poisons Act 1933 was in force. In cases decided in 1943 and 1953, the courts decided that a pharmacist who was upstairs when a supply was made could not have been supervising; and that a sale was supervised by pharmacist standing at the cash desk because the pharmacist could intervene if a sale would not be appropriate.
pharmacybiz

DNP:RPS urges social media to ban content promoting,selling - 0 views

  •  
    The Royal Pharmaceutical Society (RPS) has called for a 'firm commitment' to prosecuting those making profits through the sale of DNP (2,4-Dinitrophenol). It has also urged the social media companies to 'remove content promoting or selling DNP to further reduce harm'. Legislation to regulate DNP will come into effect on 1 October 2023. On Monday (23 January) it was announced that DNP will be included in the 1972 Poisons Act. President of RPS Professor Claire Anderson said: "DNP is unfit for human consumption and its main use is in the manufacture of explosives and pesticides. It is sold by unscrupulous dealers to vulnerable individuals wanting to lose weight but has a dangerous effect on the metabolism and has led to 32 deaths since 2007 in those taking it as a 'diet drug'. "Including DNP in the Poisons Act is a positive move as it will restrict its availability, but what's really needed is an outright ban to reduce the risk to the public. Australia has already classified DNP as a substance of such a danger to health as to warrant prohibition of sale and we'd like the UK to follow suit.
pharmacybiz

Parliamentarians call on PM to act for pharmacy closures - 0 views

  •  
    Two dozen parliamentarians from across the political spectrum have called on the prime minister to act as a wave of pharmacy closures in recent years has threatened to spiral out of control. A letter to the prime minister signed by 24 MPs and peers has warned that worse could be yet to come after "spiralling business costs" and "year after year of real terms funding cuts" have led to hundreds of pharmacy closures. New data from the PSNC shows that over 639 local pharmacies have been lost in England since 2016. "This is the equivalent to just short of one pharmacy closure per constituency", the cross-party group warned. The letter comes as MPs came together at a parliamentary summit to call for pharmacies to be embraced as a "game-changer" for tackling healthcare backlogs and taking pressure off other areas of the NHS. A 'Future of Pharmacy' event was attended by 53 parliamentarians on July 5 in the Palace of Westminster. At the event parliamentarians heard directly from frontline pharmacists and representatives of pharmacy bodies where a map of constituency-specific pharmacy numbers was also unveiled, with details of the number of pharmacy closures in MPs' local area.
pharmacybiz

Schizophrenia Treatment:New J & J Drug Authorised In UK - 0 views

  •  
    In what's seen as a major step forward for the treatment of schizophrenia, the Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised a new Johnson & Johnson drug in Britain. Byannli is a six-monthly paliperidone palmitate (PP6M) and is the first long-acting injectable schizophrenia treatment which offers patients the potential for up to six months of symptom control and a reduction in their risk of relapse with only two doses a year. It is a long-acting injectable that works by dissolving and entering the bloodstream slowly, due to its extremely low water solubility, resulting in continuous absorption of paliperidone palmitate over a six-month period. "Schizophrenia is a chronic and severe brain disorder, and antipsychotic medication plays an important role in its treatment. However, many people with the illness experience relapses which are often caused by poor adherence to oral medication," said Prof David Taylor, director of Pharmacy and Pathology at the Maudsley Hospital.
pharmacybiz

NIR health minister condemns attack on Belfast pharmacist - 0 views

  •  
    Northern Ireland's health minister Robin Swann has condemned the act of violence experienced by pharmacy teams, stating such acts "will not be tolerated." His statement follows an ugly incident that took place on Saturday (March 5) at the Teagues Pharmacy, Antrim Road in Belfast, Northern Ireland. Conor McAreavey from Teagues Pharmacy told the BBC that on Saturday a man entered the shop at about 17:30 GMT and used a hammer to break through a Covid protection screen, and stabbed him in hand before fleeing the premises. He added that such attacks on pharmacists had become a "trend". Condemning the attack, Swann said: "Abuse or assaults of any kind on health and social care staff will not be tolerated. I was appalled to hear of the assault on the community pharmacist at the weekend.
1 - 20 of 147 Next › Last »
Showing 20 items per page